Physician profile
Edward J Donner
NPI 1710968185
$2,470,892.31
in general payments reported to CMS, 2019-2025
48 companies · $484K in 2025
The $484K reported for 2025 was more than what 99% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513K · 2020: $254K · 2021: $311K · 2022: $228K · 2023: $333K · 2024: $348K · 2025: $484K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1.2M · Food and Beverage: $3,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,162,150.00 |
| Food and Beverage | $3,067.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Technology, LLC | $2,262,817.40 | 2019-2025 | Si-Technology Si-Desis X Implant, Si-Technology Si-Desis Screws, Si-Technology Si-Desis Screws |
| Jcbd, LLC | $187,900.00 | 2024-2025 | Si-Technology Si-Desis X Implant, Si-Technology Si-Desis Screws |
| Surgalign Spine Technologies, INC. | $9,217.84 | 2021-2022 | |
| Cerapedics INC. | $5,371.73 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Kyocera Medical Technologies, INC. | $787.11 | 2022-2023 | |
| Amgen INC. | $518.85 | 2019-2023 | Prolia, Evenity |
| Medtronic USA, INC. | $492.56 | 2019-2020 | |
| Si-Bone, INC. | $374.49 | 2019-2025 | |
| Radius Health, INC. | $287.05 | 2019-2023 | Tymlos |
| Nevro Corp. | $274.25 | 2023 | Senza |
| Abbott Laboratories | $215.54 | 2021-2024 | Eterna |
| Lilly USA, LLC | $188.64 | 2019-2024 | Emgality, Reyvow |
| Pfizer INC. | $186.48 | 2019-2024 | |
| Painteq LLC | $184.69 | 2023 | Painteq |
| Spinal Elements, INC. | $153.67 | 2020-2023 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $138.00 | 2024 | Spine & Trauma 3d Navigation |
| Spinal Simplicity, LLC | $135.50 | 2024 | Ha Minuteman G3-R |
| Mis Technologies, LLC | $126.37 | 2021 | |
| Centinel Spine, LLC | $125.28 | 2019-2024 | Prodisc C Vivo |
| Orthofix Medical, INC. | $122.64 | 2021 | |
| Depuy Synthes Sales INC. | $118.26 | 2022 | |
| Ferring Pharmaceuticals INC. | $110.33 | 2025 | |
| Curonix LLC | $107.53 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Highridge Medical LLC | $96.11 | 2025 | Vital |
| Terumo Bct, INC. | $88.88 | 2019 | |
| Djo, LLC | $84.07 | 2023 | Cmf |
| Biohaven Pharmaceutical Holding Company Ltd. | $74.20 | 2022 | |
| Kuros Biosciences USA, INC | $68.49 | 2024 | Magnetos |
| Nalu Medical, INC. | $62.81 | 2021-2022 | |
| Intrinsic Therapeutics | $50.34 | 2023 | Barricaid Acd (Annular Closure Device) |
| Eisai INC. | $46.62 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $41.69 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $37.01 | 2021 | |
| Nuvasive, INC. | $33.51 | 2021 | |
| Davol INC. | $33.30 | 2022 | |
| Stryker Corporation | $24.61 | 2022 | |
| Abbvie INC. | $19.65 | 2023 | Botox |
| Alfasigma USA, INC. | $19.05 | 2021 | |
| Integra Lifesciences Corporation | $18.17 | 2021 | |
| Mml US, INC. | $17.87 | 2023 | Reactiv8 |
| Medtronic, INC. | $17.63 | 2023 | Plasmablade(Tm) |
| Zimmer Biomet Holdings, INC. | $17.48 | 2019 | |
| Alvogen INC | $17.34 | 2023 | Teriparatide |
| Redhill Biopharma INC. | $15.76 | 2021 | |
| Misonix INC | $15.58 | 2019 | |
| International Rehabilitative Sciences, INC | $14.33 | 2024 | Rs 4i Plus Sequential Stimulator |
| Augmedics INC. | $13.16 | 2021 | |
| Globus Medical, INC. | $10.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$46,388,407.45 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Donner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.